Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05411835 · ClinicalTrials.gov registry record · Early Phase 1
Oral Ketones and Exercise Among Patients With Long-chain Fatty Acid Oxidation Disorders
A Early Phase 1 study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 5
- Enrollment target
NCT05411835: Completed Early Phase 1 study, sponsored by Oregon Health and Science University.
NCT05411835 is a Early Phase 1 study that has completed, run by Oregon Health and Science University. The registered enrollment target is 5 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05411835, a Early Phase 1 study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
The purpose of the study is to determine if an oral ketone beverage is safe and well-tolerated during moderate intensity exercise in participants with long-chain fatty acid oxidation disorders and if it will raise blood ketones to levels similar to that reported among normal healthy subjects.
Primary Outcome
Number of Adverse events
Interventions
- DIETARY_SUPPLEMENT Nutritional Ketone Supplement
- DIETARY_SUPPLEMENT Isocaloric Placebo Supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2022-08-01 |
| Est. Completion | 2024-01-22 |
| Phase | Early Phase 1 |
What the finished NCT05411835 record still lists
NCT05411835 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 2 interventions - of which Nutritional Ketone Supplement is the first listed.
NCT05411835 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05411835 about?
NCT05411835 is a clinical study titled "Oral Ketones and Exercise Among Patients With Long-chain Fatty Acid Oxidation Disorders". The purpose of the study is to determine if an oral ketone beverage is safe and well-tolerated during moderate intensity exercise in participants with long-chain fatty acid oxidation disorders and if it will raise blood ketones to levels similar to that reported among normal healthy subjects.
What is the current status of trial NCT05411835?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 5 participants. The study started on 2022-08-01. Estimated completion is 2024-01-22.
What interventions are being tested in trial NCT05411835?
The interventions under investigation include: Nutritional Ketone Supplement (DIETARY_SUPPLEMENT), Isocaloric Placebo Supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05411835?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05411835's enrollment target sits among peer trials
5 1887th of 2000 higher than 80 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI